These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 22127311)

  • 1. Genomic profiling of B-progenitor acute lymphoblastic leukemia.
    Mullighan CG
    Best Pract Res Clin Haematol; 2011 Dec; 24(4):489-503. PubMed ID: 22127311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How new advances in genetic analysis are influencing the understanding and treatment of childhood acute leukemia.
    Roberts KG; Mullighan CG
    Curr Opin Pediatr; 2011 Feb; 23(1):34-40. PubMed ID: 21169835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular genetic makeup of acute lymphoblastic leukemia.
    Mullighan CG
    Hematology Am Soc Hematol Educ Program; 2012; 2012():389-96. PubMed ID: 23233609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia.
    Shiraz P; Payne KJ; Muffly L
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32235787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.
    Harvey RC; Mullighan CG; Chen IM; Wharton W; Mikhail FM; Carroll AJ; Kang H; Liu W; Dobbin KK; Smith MA; Carroll WL; Devidas M; Bowman WP; Camitta BM; Reaman GH; Hunger SP; Downing JR; Willman CL
    Blood; 2010 Jul; 115(26):5312-21. PubMed ID: 20139093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party.
    Iacobucci I; Lonetti A; Paoloni F; Papayannidis C; Ferrari A; Storlazzi CT; Vignetti M; Cilloni D; Messa F; Guadagnuolo V; Paolini S; Elia L; Messina M; Vitale A; Meloni G; Soverini S; Pane F; Baccarani M; Foà R; Martinelli G
    Haematologica; 2010 Oct; 95(10):1683-90. PubMed ID: 20534699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates.
    Boer JM; Koenders JE; van der Holt B; Exalto C; Sanders MA; Cornelissen JJ; Valk PJ; den Boer ML; Rijneveld AW
    Haematologica; 2015 Jul; 100(7):e261-4. PubMed ID: 25769542
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood.
    Schmäh J; Fedders B; Panzer-Grümayer R; Fischer S; Zimmermann M; Dagdan E; Bens S; Schewe D; Moericke A; Alten J; Bleckmann K; Siebert R; Schrappe M; Stanulla M; Cario G
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.
    Mullighan CG; Goorha S; Radtke I; Miller CB; Coustan-Smith E; Dalton JD; Girtman K; Mathew S; Ma J; Pounds SB; Su X; Pui CH; Relling MV; Evans WE; Shurtleff SA; Downing JR
    Nature; 2007 Apr; 446(7137):758-64. PubMed ID: 17344859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia.
    Duque-Afonso J; Feng J; Scherer F; Lin CH; Wong SH; Wang Z; Iwasaki M; Cleary ML
    J Clin Invest; 2015 Sep; 125(9):3667-80. PubMed ID: 26301816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting signaling pathways in acute lymphoblastic leukemia: new insights.
    Harrison CJ
    Hematology Am Soc Hematol Educ Program; 2013; 2013():118-25. PubMed ID: 24319172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Characterization of Novel Fusion Genes with Potential Clinical Applications in Mexican Children with Acute Lymphoblastic Leukemia.
    Mata-Rocha M; Rangel-López A; Jiménez-Hernández E; Morales-Castillo BA; González-Torres C; Gaytan-Cervantes J; Álvarez-Olmos E; Núñez-Enríquez JC; Fajardo-Gutiérrez A; Martín-Trejo JA; Solís-Labastida KA; Medina-Sansón A; Flores-Lujano J; Sepúlveda-Robles OA; Peñaloza-González JG; Espinoza-Hernández LE; Núñez-Villegas NN; Espinosa-Elizondo RM; Cortés-Herrera B; Torres-Nava JR; Flores-Villegas LV; Merino-Pasaye LE; Bekker-Méndez VC; Velázquez-Aviña MM; Pérez-Saldívar ML; Bautista-Martínez BA; Amador-Sánchez R; González-Avila AI; Jiménez-Morales S; Duarte-Rodríguez DA; Santillán-Juárez JD; García-Velázquez AJ; Rosas-Vargas H; Mejía-Aranguré JM
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IKZF1 alterations in acute lymphoblastic leukemia: The good, the bad and the ugly.
    Vairy S; Tran TH
    Blood Rev; 2020 Nov; 44():100677. PubMed ID: 32245541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia.
    Schinnerl D; Fortschegger K; Kauer M; Marchante JR; Kofler R; Den Boer ML; Strehl S
    Blood; 2015 Feb; 125(8):1282-91. PubMed ID: 25515960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss-of-function but not dominant-negative intragenic
    Kobitzsch B; Gökbuget N; Schwartz S; Reinhardt R; Brüggemann M; Viardot A; Wäsch R; Starck M; Thiel E; Hoelzer D; Burmeister T
    Haematologica; 2017 Oct; 102(10):1739-1747. PubMed ID: 28751559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
    Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
    Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Landscape of Adult and Pediatric
    Severson EA; Vergilio JA; Gay LM; Daniel S; Hemmerich AC; Elvin JA; Britt N; Nahas M; Cohen MB; Brown C; Sathyan P; Rankin A; Miller V; Ross JS; Ramkissoon SH
    Oncologist; 2019 Mar; 24(3):372-374. PubMed ID: 30181314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia.
    Steeghs EMP; Boer JM; Hoogkamer AQ; Boeree A; de Haas V; de Groot-Kruseman HA; Horstmann MA; Escherich G; Pieters R; den Boer ML
    Sci Rep; 2019 Mar; 9(1):4634. PubMed ID: 30874617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
    Mullighan CG; Su X; Zhang J; Radtke I; Phillips LA; Miller CB; Ma J; Liu W; Cheng C; Schulman BA; Harvey RC; Chen IM; Clifford RJ; Carroll WL; Reaman G; Bowman WP; Devidas M; Gerhard DS; Yang W; Relling MV; Shurtleff SA; Campana D; Borowitz MJ; Pui CH; Smith M; Hunger SP; Willman CL; Downing JR;
    N Engl J Med; 2009 Jan; 360(5):470-80. PubMed ID: 19129520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strategies in acute lymphoblastic leukemia: translating advances in genomics into clinical practice.
    Mullighan CG
    Clin Cancer Res; 2011 Feb; 17(3):396-400. PubMed ID: 21149616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.